文献速递衰弱、肌少症与跌倒老年慢病共病管理

衰弱负担与慢性冠心病初始侵入性策略疗效:ISCHEMIA试验

Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials.
PubMed 文献 · J Am Geriatr Soc · 2025-05-14

该研究为ISCHEMIA与ISCHEMIA-CKD试验的汇总事后分析,共5322例慢性冠心病患者,用衰弱指数分为三组。结果显示高衰弱负担不改变初始侵入性策略对主要复合终点的影响(P交互=0.30),但显著修饰生活质量效应,高衰弱组侵入性治疗1年SAQ改善更大(P交互<0.001)。

要点

  • 高衰弱负担与较低基线SAQ评分及更高不良临床结局风险相关。
  • 衰弱负担未显著修饰初始侵入性策略对主要复合终点的影响(P交互=0.30)。
  • 高衰弱负担者接受初始侵入性策略1年SAQ改善更大(P交互<0.001)。

核心结论

  • 高衰弱负担的慢性冠心病患者接受初始侵入性管理可能获得更大生活质量改善,且不增加不良临床事件风险。

研究设计与样本

  • ISCHEMIA与ISCHEMIA-CKD试验的汇总事后分析,共5322例参与者,平均64岁,24%女性。
  • 基线衰弱用衰弱指数评估,参与者按数据推导的三分位分组。
  • 采用多变量Cox模型及乘法交互项评估衰弱是否修饰初始侵入性策略与保守策略的治疗效应。

主要发现

  • 高衰弱负担(三分位3 vs 三分位1)与较低基线SAQ评分及随访中更高不良临床结局风险相关。
  • 基线衰弱负担未显著修饰初始侵入性策略对主要复合终点的影响(P交互=0.30)。
  • 衰弱显著修饰初始侵入性策略对HRQoL的影响,高基线衰弱负担与1年SAQ评分更大改善相关(P交互<0.001)。
  • 在高低衰弱负担组中,基线SAQ评分较低者接受初始侵入性策略的12个月SAQ评分改善最明显。

关键数值与推荐

  • 主要复合终点包括心血管死亡、心肌梗死、不稳定型心绞痛住院、心力衰竭或复苏成功的心脏骤停。
  • 次要结局为HRQoL,采用西雅图心绞痛问卷(SAQ)评估。

临床怎么用

  • 对慢性冠心病合并高衰弱负担患者,初始侵入性策略可能带来更大生活质量获益而不增加不良临床事件风险。
  • 基线SAQ评分较低者可预测初始侵入性管理后HRQoL改善更大,且该预测独立于衰弱负担。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty is common among patients with chronic coronary disease and is associated with worse outcomes. METHODS: A pooled, post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials was conducted. Baseline frailty was assessed using a Frailty Index (FI), and participants were categorized into data-derived tertiles. Multivariable Cox models with multiplicative interaction terms (frailty × treatment arm) were constructed to evaluate whether baseline frailty status modified the treatment effect of the initial invasive (vs conservative) strategy on a composite outcome of cardiovascular death, myocardial infarction, hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest and the secondary outcome of HRQoL (Seattle Angina Questionnaire [SAQ]). RESULTS: Among 5322 participants (mean 64 years, 24% female), a high frailty burden (tertile 3 vs. tertile 1) was associated with lower baseline SAQ scores and increased risk of adverse clinical outcomes on follow-up. Baseline frailty burden did not significantly modify the effect of the initial invasive strategy on the primary composite outcome (P interactionfrailty × intervention arm = 0.30). However, frailty significantly modified the effect of the initial invasive strategy on HRQoL, with higher baseline frailty burden associated with greater improvement in SAQ scores at 1 year with initial invasive (vs. conservative) treatment (P interactionfrailty × intervention arm < 0.001). The treatment effect of an initial invasive vs. conservative strategy on 12-month SAQ score change was most pronounced in individuals with lower baseline SAQ scores in both higher and lower frailty burden groups. CONCLUSION: Patients with chronic coronary disease with a higher frailty burden are more likely to experience greater improvements in HRQoL with initial invasive management without a higher risk of adverse clinical events. Lower baseline SAQ scores predicted greater improvement in HRQoL with initial invasive management, independent of frailty burden.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Patel L, Segar MW, Usman MS, et al. Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials. J Am Geriatr Soc. 2025. PMID: 40365856. doi:10.1111/jgs.19508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。